A Study of VI-0521 on Ambulatory Blood Pressure (ABPM) in Overweight or Obese Subjects

NCT05215418 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

565

Enrollment

INDUSTRY

Sponsor class

Conditions

Blood Pressure

Interventions

DRUG: VI-0521
DRUG: Phentermine
DRUG: Placebo

Sponsor

VIVUS LLC